InvestorsHub Logo
Followers 617
Posts 27445
Boards Moderated 3
Alias Born 11/16/2007

Re: 58nout post# 83269

Thursday, 12/18/2014 5:29:17 PM

Thursday, December 18, 2014 5:29:17 PM

Post# of 402807
As a patient, which antibiotic would you choose for ABSSSI? A single iv dose one time for one day, or a single iv dose daily for 7 to 14 days. It wouldn't take much marketing for me to try Brilacidin to cut my IV time along with the shorter hospital stay.

I'm not even going to guess which large pharma wants to partner with Cellceutix for Brilacidin.




In Reply to '58nout'
Karin this is correct but with the caveat that dapto revenue which is currently over 1B a year is more than double that of vanco. This brings to light the fact that with the coming generic availability of dapto which will not go away just as vanco never went away, Cellceutix will need the strength of a major partner who has the muscle to sell the Brilicidan story of superiority in cost effectiveness. I still have my money on Novartis.

GO CTIX




To follow KarinCA, click here then click "Follow This Member" under my photo.

Be kinder than necessary, for everyone you meet is fighting some kind of battle.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News